Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 72.416 |
|
|||||
| News | - | ||||||
| Tageshoch | 25,245 | Niedrig Hoch |
|||||
| Tagestief | 23,90 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Jasper Therapeutics Inc | JSPR | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,96 | 3,94% | 25,30 | 00:17:05 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 24,40 | 23,90 | 25,245 | 25,02 | 24,34 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 1.720 | 72.416 | US$ 24,38 | US$ 1.765.686 | - | 4,00 - 31,01 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 01:57:30 | 1 | US$ 24,56 | USD |
Option-Flow Jasper Therapeutics (JSPR)
Finanzwerte JSPR
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 377,5M | 15,06M | - | 0 | -64,47M | -4,28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Jasper Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 05.3.2024 | 22:52 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 05.3.2024 | 22:02 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 04.3.2024 | 13:40 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21.2.2024 | 01:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 21.2.2024 | 01:22 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 10.2.2024 | 02:36 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 06.2.2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 02.2.2024 | 15:50 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 04.1.2024 | 12:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 02.1.2024 | 14:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20.12.2023 | 12:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20.11.2023 | 23:11 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
Forum Jasper Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
JSPR Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 24,8864 | 25,40 | 23,36 | 24,17 | 93.507 | 0,4136 | 1,66% |
| 1 Monat | 22,80 | 26,835 | 22,135 | 24,42 | 103.006 | 2,50 | 10,96% |
| 3 Monate | 30,06 | 31,01 | 20,15 | 24,80 | 82.614 | -4,76 | -15,83% |
| 6 Monate | 4,358 | 31,01 | 4,235 | 13,23 | 195.386 | 20,94 | 480,54% |
| 1 Jahr | 17,40 | 31,01 | 4,00 | 9,81 | 318.533 | 7,90 | 45,40% |
| 3 Jahre | 140,60 | 188,80 | 3,862 | 56,48 | 791.555 | -115,30 | -82,01% |
| 5 Jahre | 140,60 | 188,80 | 3,862 | 56,48 | 791.555 | -115,30 | -82,01% |
